UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$438M |
| 2 |
Lockheed Martin
LMT
|
+$402M |
| 3 |
TAL Education Group
TAL
|
+$294M |
| 4 |
Microsoft
MSFT
|
+$269M |
| 5 |
Wells Fargo
WFC
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$384M |
| 2 |
Adobe
ADBE
|
+$372M |
| 3 |
Veeva Systems
VEEV
|
+$342M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$289M |
| 5 |
Global Payments
GPN
|
+$287M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.1% |
| 2 | Consumer Discretionary | 13.57% |
| 3 | Healthcare | 12.46% |
| 4 | Financials | 11.55% |
| 5 | Communication Services | 9.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
PRA Group
PRAA
$714M
| $1.93M | ﹤0.01% |
48,648
| – | – |
|
|
AVYA
1652
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $1.91M | ﹤0.01% |
99,612
-9,356
| -9% | -$174K |
|
1653
Upbound Group
UPBD
$1.12B
| $1.9M | ﹤0.01% |
49,741
+3,384
| +7% | +$115K |
|
1654
JELD-WEN Holding
JELD
$162M
| $1.9M | ﹤0.01% |
75,069
+11,386
| +18% | +$273K |
|
|
PDCE
1655
DELISTED
PDC Energy, Inc.
PDCE
| $1.89M | ﹤0.01% |
92,219
+4,352
| +5% | +$68K |
|
1656
Red Rock Resorts
RRR
$3.62B
| $1.88M | ﹤0.01% |
75,219
-5,419
| -7% | -$115K |
|
1657
BioCryst Pharmaceuticals
BCRX
$2.51B
| $1.88M | ﹤0.01% |
252,625
-908,530
| -78% | -$4.68M |
|
1658
Monro
MNRO
$368M
| $1.88M | ﹤0.01% |
35,180
-4,086
| -10% | -$187K |
|
|
ECHO
1659
EchoStar
ECHO
$25.9B
| $1.87M | ﹤0.01% |
88,403
+3,976
| +5% | +$95.1K |
|
1660
Abercrombie & Fitch
ANF
$5.27B
| $1.87M | ﹤0.01% |
91,990
+12,064
| +15% | +$221K |
|
1661
Kulicke & Soffa
KLIC
$4.53B
| $1.87M | ﹤0.01% |
58,826
| – | – |
|
1662
First Merchants
FRME
$2.66B
| $1.87M | ﹤0.01% |
50,014
-7,172
| -13% | -$223K |
|
|
MGLN
1663
DELISTED
Magellan Health Services, Inc.
MGLN
| $1.87M | ﹤0.01% |
22,581
+3,097
| +16% | +$245K |
|
|
SFBS
1664
ServisFirst Bancshares
SFBS
$4.84B
| $1.86M | ﹤0.01% |
46,088
| – | – |
|
|
EIDX
1665
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $1.85M | ﹤0.01% |
14,057
+4,700
| +50% | +$415K |
|
1666
Piper Sandler
PIPR
$5.29B
| $1.84M | ﹤0.01% |
73,104
| – | – |
|
1667
Bloomin' Brands
BLMN
$944M
| $1.84M | ﹤0.01% |
94,952
+7,316
| +8% | +$125K |
|
1668
Lemonade
LMND
$4.08B
| $1.84M | ﹤0.01% |
+15,038
| New | +$1.11M |
|
1669
Acushnet Holdings
GOLF
$5.34B
| $1.84M | ﹤0.01% |
45,375
-1,197
| -3% | -$44.7K |
|
1670
InterDigital
IDCC
$8.99B
| $1.84M | ﹤0.01% |
30,248
+159
| +0.5% | +$9.52K |
|
1671
Shutterstock
SSTK
$218M
| $1.83M | ﹤0.01% |
25,557
+6,097
| +31% | +$405K |
|
|
MRSN
1672
DELISTED
Mersana Therapeutics
MRSN
| $1.81M | ﹤0.01% |
2,727
+209
| +8% | +$116K |
|
1673
NETSCOUT
NTCT
$2.81B
| $1.81M | ﹤0.01% |
65,993
-12,832
| -16% | -$307K |
|
1674
Trustmark
TRMK
$2.75B
| $1.81M | ﹤0.01% |
66,133
-12,181
| -16% | -$305K |
|
1675
Cushman & Wakefield Ltd
CWK
$3.12B
| $1.8M | ﹤0.01% |
121,611
| – | – |
|
Similar funds
UBS AM's Q4 2020 Portfolio in Review
As of Q4 2020, UBS AM held 2,632 positions worth $213B, up 15% from $186B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
UBS AM's Q4 2020 filing shows 139 new, 1,393 increased, 625 reduced and 83 closed positions. Its largest new stake was Maravai LifeSciences: 3,763,012 shares worth $106M. The largest sale was Mastercard, an estimated $384M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- UBS AM's largest Q4 2020 buy was Maravai LifeSciences: 3,763,012 shares worth $106M.
- UBS AM added most to Apple in Q4 2020, an estimated $438M increase.
- UBS AM's biggest Q4 2020 reduction was Mastercard, cutting an estimated $384M.
- UBS AM fully exited State Street Technology Select Sector SPDR ETF in Q4 2020, selling an estimated $115M.
- UBS AM's ten largest holdings make up 23% of its $213B portfolio in Q4 2020.
- UBS AM opened 139 new positions and closed 83 in Q4 2020.
- UBS AM's portfolio value rose 15% quarter-over-quarter to $213B.
Based on UBS AM's 13F filing for Q4 2020, filed 17 Feb 2021.